Stoke Therapeutics Inc (NASDAQ:STOK)

13.60
Delayed Data
As of Jun 24
 -0.33 / -2.37%
Today’s Change
9.55
Today|||52-Week Range
37.15
-43.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2017

2018

--

--
Operating ActivitiesNet Income / Starting Line-5.6M-12.5M----
 
 
 
Depreciation113.0K214.0K----
 
 
 
Total Other Cash Flow30.0K250.0K----
 
 
 
Funds From Operations-5.4M-12.1M----
 
 
 
Funds From/For Other Operating Expenses-31.0K-1.1M----
 
 
 
Net Cash Flow - Operating Activities-5.4M-11.0M----
 
 
 
 
InvestingCapital Expenditures-113.0K-935.0K----
 
 
 
Fixed Asset Disposal0.0010.0K----
 
 
Net Cash Flow Investing-113.0K-925.0K----
 
 
 
 
FinancingShort Term Borrowings3.0M0.00----
 
 
Long Term Borrowings0.000.00------
Long Term Debt Reduction0.000.00------
Net Proceeds Stock Sale3.0M115.6M----
 
 
 
Common Preferred Redeemed0.000.00------
Common Dividends0.000.00------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing0.000.00------
Other Uses - Financing1.0K2.0K----
 
 
 
Net Cash Flow - Financing6.0M115.6M----
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash477.0K103.8M----